Long-term efficacy and tolerability of quetiapine in treatment-refractory schizophrenia: A case study

被引:0
|
作者
Reznik, I [1 ]
Benatov, R
Sirota, P
机构
[1] Abarbanel Mental Hlth Ctr, Bat Yam, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel
关键词
D O I
暂无
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:16 / 16
页数:1
相关论文
共 50 条
  • [31] THE PHARMACOEPIDEMIOLOGY OF TREATMENT-REFRACTORY SCHIZOPHRENIA
    COLLINS, EJ
    HOGAN, TP
    AWAD, AG
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1992, 37 (03): : 192 - 195
  • [32] RISPERIDONE FOR TREATMENT-REFRACTORY SCHIZOPHRENIA
    TANNER, TB
    GANGULI, R
    REDDY, R
    ALLEN, M
    FIELD, K
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (08): : 1233 - 1233
  • [33] OLANZAPINE MONOTHERAPY IN A LONG-TERM TREATMENT FOR SCHIZOPHRENIA: CASE STUDY
    Ruzic, Klementina
    Dadic-Hero, Elizabeta
    Petranovic, Duska
    Medved, Paola
    [J]. PSYCHIATRIA DANUBINA, 2009, 21 (01) : 119 - 121
  • [34] Treatment-refractory schizophrenia.
    Buckley P.F.
    Wiggins L.D.
    Sebastian S.
    Singer B.
    [J]. Current Psychiatry Reports, 2001, 3 (5) : 393 - 400
  • [35] Long-term treatment of neuropathic pain and fibromyalgia syndrome with pregabalin in treatment-refractory patients
    Siffert, J
    Dworkin, RH
    Sharma, U
    Stacey, B
    Chambers, R
    [J]. NEUROLOGY, 2005, 64 (06) : A121 - A122
  • [36] The long-term efficacy and safety of 'Seroquel' (quetiapine)
    Arvanitis, LA
    Rak, IW
    [J]. SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 196 - 197
  • [37] The long-term efficacy of cannabidiol in the treatment of refractory epilepsy
    Patel, Sandip
    Grinspoon, Reid
    Fleming, Bradley
    Skirvin, Lauren A.
    Wade, Christina
    Wolper, Emma
    Bruno, Patricia L.
    Thiele, Elizabeth A.
    [J]. EPILEPSIA, 2021, 62 (07) : 1594 - 1603
  • [38] Long-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of Fibromyalgia
    Mease, Philip J.
    Russell, I. Jon
    Kajdasz, Daniel K.
    Wiltse, Curtis G.
    Detke, Michael J.
    Wohlreich, Madelaine M.
    Walker, Daniel J.
    Chappell, Amy S.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 39 (06) : 454 - 464
  • [39] Monotherapy and long-term treatment: efficacy onset and tolerability - Comment
    Schmidt, D
    Schachter, SC
    [J]. EPILEPSY & BEHAVIOR, 2003, 4 : S42 - S43
  • [40] Treatment of overactive bladder: long-term tolerability and efficacy of tolterodine
    R. A. Appell
    P. Abrams
    H. P. Drutz
    P. E. V. A. Van Kerrebroeck
    R. Millard
    A. Wein
    [J]. World Journal of Urology, 2001, 19 : 141 - 147